Ernexa Therapeutics Inc. - Common Stock — Filings & Documents (NASDAQ:ERNA) — Page 16 | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

1995

Quarterly report, Q2 FY1995

Ernexa Therapeutics Inc. quarterly report, Q2 FY1995

News

Ernexa Therapeutic To Present New Preclinical Data From Its ERNA-101 Lead Oncology Program At The Next-Generation Cancer Therapeutics Meeting, October 6–8

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Ernexa Therapeutics Announces Encouraging Results From Three Core IND-Enabling Safety Studies Of ERNA-101, Lead Synthetic, Allogeneic iMSC Therapy Engineered To Express IL-7/IL-15 Fusion Cytokine

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

3 Most Active Penny Stocks to Watch Today, 7/16/2026 - TipRanks.com

ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know

3 Penny Stocks to Watch Now, 5/7/26 - TipRanks.com

Upcoming Stock Splits This Week (May 4 to May 8) – Stay Invested - TipRanks.com

Ernexa therapeutics ten percent owner Cherington buys $2m in stock

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.47%